Chain elongators, friends, and foes.


Journal

Current opinion in biotechnology
ISSN: 1879-0429
Titre abrégé: Curr Opin Biotechnol
Pays: England
ID NLM: 9100492

Informations de publication

Date de publication:
02 2021
Historique:
received: 19 09 2020
revised: 02 01 2021
accepted: 07 01 2021
pubmed: 3 2 2021
medline: 27 4 2021
entrez: 2 2 2021
Statut: ppublish

Résumé

Bioproduction of medium chain carboxylic acids has recently emerged as an alternative strategy to valorize low-value organic waste and side-streams. Key to this route is chain elongation, an anaerobic microbial process driven by ethanol, lactic acid, or carbohydrates. Because these technologies use wastes as feedstocks, mixed microbial communities are often considered as biocatalysts. Understanding and steering these microbiomes is key to optimize bioprocess performance. From a meta-analysis of publicly available sequencing data, we (i) explore how the current collection of isolated chain elongators compares to microbiome members, (ii) discuss the main beneficial and antagonistic interactions with community partners, and (iii) identify the key research gaps and needs to help understand chain elongation microbiomes, and design/steer these novel bioproduction processes.

Identifiants

pubmed: 33529974
pii: S0958-1669(21)00010-0
doi: 10.1016/j.copbio.2021.01.005
pii:
doi:

Substances chimiques

Carbohydrates 0
Lactic Acid 33X04XA5AT

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

99-110

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Pieter Candry (P)

Civil and Environmental Engineering, University of Washington, 201 More Hall, Box 352700, Seattle, WA 98195-2700, USA.

Ramon Ganigué (R)

Center for Microbial Ecology and Technology (CMET), Ghent University, Coupure Links 653, 9000 Ghent, Belgium. Electronic address: Ramon.Ganigue@UGent.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH